ValuEngine Lowers Helius Medical Technologies (HSDT) to Sell

ValuEngine cut shares of Helius Medical Technologies (OTCMKTS:HSDT) from a hold rating to a sell rating in a report released on Friday morning.

Helius Medical Technologies (HSDT) opened at $2.23 on Friday. Helius Medical Technologies has a twelve month low of $1.29 and a twelve month high of $4.14.

In other news, Director Dane Andreeff purchased 167,000 shares of the stock in a transaction on Monday, November 13th. The stock was bought at an average price of $2.58 per share, for a total transaction of $430,860.00. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Blane Walter purchased 40,000 shares of the stock in a transaction on Friday, November 17th. The shares were purchased at an average price of $2.46 per share, with a total value of $98,400.00. The disclosure for this purchase can be found here. Insiders own 23.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “ValuEngine Lowers Helius Medical Technologies (HSDT) to Sell” was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at https://www.com-unik.info/2017/12/04/valuengine-lowers-helius-medical-technologies-hsdt-to-sell.html.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device.

To view ValuEngine’s full report, visit ValuEngine’s official website.

What are top analysts saying about Helius Medical Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Helius Medical Technologies Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit